SCHEMBL20176568

SCHEMBL20176568

Brc1ccc(-c2c3ccccc3c(-c3ccccc3)c3cc(-c4ccc(-c5nc6ccccc6n5-c5ccccc5)cc4)ccc23)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
HDAC1 Q13547 3/20 0.42
HDAC8 Q9BY41 3/20 0.42
HDAC6 Q9UBN7 3/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HSP90AA1 P07900 1/20 0.41
MAPT P10636 1/20 0.41
GRIA1 P42261 1/20 0.41
CACNG8 Q8WXS5 1/20 0.41
CACNG2 Q9Y698 1/20 0.41
PTGER4 P35408 1/20 0.39
HTT P42858 2/20 0.38
GAA P10253 2/20 0.38
MAPK1 P28482 1/20 0.38
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
PTGS2 P35354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18999498 0.90 ESR1 (0.56) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL30428855 0.90 ESR1 (0.56) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL19008526 0.90 ESR1 (0.56) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL13158626 0.90 ESR1 (0.56) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL35693 0.90 ESR1 (0.56) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL18925698 0.90 ESR1 (0.56) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL19309014 0.89 ESR1 (0.58) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL18999510 0.89 ESR1 (0.57) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL11953890 0.89 ESR1 (0.57) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL23784962 0.88 ESR1 (0.59) ESR1ESR2HDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
WO-2018093231-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME 주식회사 두산 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same OR10J3, ICMT, SLCO4C1 ESR1 310/4885ESR2 934/4885HDAC1 4481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.